Suchergebnisse - "Koranyi, L"

PubPharm (12)

1

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy : a randomised trial

enthalten in: The lancet. Diabetes & endocrinology | 2015

von de Zeeuw, D. | Bekker, P. | Henkel, E. | +89

CommentIn: Lancet Diabetes Endocrinol. 2015 Sep;3(9):666-7. - PMID 26268909

2

Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes : a 16-week randomized, placebo-controlled clinical trial

enthalten in: Diabetes, obesity & metabolism | 2015

von Schumm-Draeger, P. | Burgess, L. | Korányi, L. | +3

3

Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders

enthalten in: Brain research bulletin | 2010

von Literáti-Nagy, B. | Péterfai, E. | Kulcsár, E. | +8

4

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone : a 52-week randomised controlled trial

enthalten in: International journal of clinical practice | 2010

von Göke, B. | Gallwitz, B. | Eriksson, J. | +103

5

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled study

enthalten in: Current medical research and opinion | 2009

von Pratley, R. | Reusch, J. | Fleck, P. | +103

6

Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients : a proof of concept randomized double-blind clinical trial

enthalten in: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme | 2009

von Literáti-Nagy, B. | Kulcsár, E. | Literáti-Nagy, Z. | +8

7

The effects of tibolone in older postmenopausal women

enthalten in: The New England journal of medicine | 2008

von Cummings, S. | Ettinger, B. | Delmas, P. | +106

CommentIn: N Engl J Med. 2008 Aug 14;359(7):753-5. - PMID 18703480

8

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease : data from the PROactive study (PROactive 08)

enthalten in: Diabetes care | 2007

von Erdmann, E. | Charbonnel, B. | Wilcox, R. | +108

9

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction : results from the PROactive (PROactive 05) Study

enthalten in: Journal of the American College of Cardiology | 2007

von Erdmann, E. | Dormandy, J. | Charbonnel, B. | +104

CommentIn: J Am Coll Cardiol. 2007 May 1;49(17):1781-2. - PMID 17466228

10

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events) : a randomised controlled trial

enthalten in: Lancet (London, England) | 2005

von Dormandy, J. | Charbonnel, B. | Eckland, D. | +128

CommentIn: Lancet. 2005 Oct 8;366(9493):1241-2. - PMID 16214581